These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30792993)

  • 21. Beijing genotype of Mycobacterium tuberculosis is significantly associated with linezolid resistance in multidrug-resistant and extensively drug-resistant tuberculosis in China.
    Zhang Z; Pang Y; Wang Y; Liu C; Zhao Y
    Int J Antimicrob Agents; 2014 Mar; 43(3):231-5. PubMed ID: 24439458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of potential urine proteins and microRNA biomarkers for the diagnosis of pulmonary tuberculosis patients.
    Wang J; Zhu X; Xiong X; Ge P; Liu H; Ren N; Khan FA; Zhou X; Zhang L; Yuan X; Chen X; Chen Y; Hu C; Robertson ID; Chen H; Guo A
    Emerg Microbes Infect; 2018 Apr; 7(1):63. PubMed ID: 29636444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limited Effect of Later-Generation Fluoroquinolones in the Treatment of Ofloxacin-Resistant and Moxifloxacin-Susceptible Multidrug-Resistant Tuberculosis.
    Lee H; Ahn S; Hwang NY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Kim CK; Koh WJ
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multidrug-resistant tuberculosis in Europe, 2010-2011.
    Günther G; van Leth F; Alexandru S; Altet N; Avsar K; Bang D; Barbuta R; Bothamley G; Ciobanu A; Crudu V; Davilovits M; Dedicoat M; Duarte R; Gualano G; Kunst H; de Lange W; Leimane V; Magis-Escurra C; McLaughlin AM; Muylle I; Polcová V; Pontali E; Popa C; Rumetshofer R; Skrahina A; Solodovnikova V; Spinu V; Tiberi S; Viiklepp P; Lange C;
    Emerg Infect Dis; 2015 Mar; 21(3):409-16. PubMed ID: 25693485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levels of tumour necrosis factor-alpha and IL-1alpha in newly diagnosed and multidrug resistant tuberculosis.
    Cağatay T; Kiran B; Yurt S; Gülbaran Z; Kosar F; Cağatay P
    Respirology; 2005 Jun; 10(3):290-4. PubMed ID: 15955139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk and outcome of multidrug-resistant tuberculosis: vitamin D receptor polymorphisms and serum 25(OH)D.
    Rathored J; Sharma SK; Singh B; Banavaliker JN; Sreenivas V; Srivastava AK; Mohan A; Sachan A; Harinarayan CV; Goswami R
    Int J Tuberc Lung Dis; 2012 Nov; 16(11):1522-8. PubMed ID: 22990231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB).
    Liu Y; Matsumoto M; Ishida H; Ohguro K; Yoshitake M; Gupta R; Geiter L; Hafkin J
    Tuberculosis (Edinb); 2018 Jul; 111():20-30. PubMed ID: 30029909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
    PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mass spectrometry-based identification of new serum biomarkers in patients with multidrug resistant pulmonary tuberculosis].
    Lin D; Wang W; Qiu F; Li Y; Yu X; Lin B; Chen Y; Lei C; Ma Y; Zeng J; Zhou J
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Dec; 39(12):1409-1420. PubMed ID: 31907157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains.
    McBryde ES; Meehan MT; Doan TN; Ragonnet R; Marais BJ; Guernier V; Trauer JM
    Int J Infect Dis; 2017 Mar; 56():14-20. PubMed ID: 28163165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum degradome markers for the detection of breast cancer.
    van Winden AW; van den Broek I; Gast MC; Engwegen JY; Sparidans RW; van Dulken EJ; Depla AC; Cats A; Schellens JH; Peeters PH; Beijnen JH; van Gils CH
    J Proteome Res; 2010 Aug; 9(8):3781-8. PubMed ID: 20557135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design.
    Mok JH; Kang BH; Lee T; Lee HK; Jang HJ; Cho YJ; Jeon D
    J Korean Med Sci; 2017 Apr; 32(4):636-641. PubMed ID: 28244290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro cytotoxicity of CD8+ T cells in multi-drug-resistant tuberculosis. A preliminary report.
    Sada-Ovalle I; Torre-Bouscoulet L; Valdez-Vázquez R; Lascurain R
    Respirology; 2009 May; 14(4):574-8. PubMed ID: 19192219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates.
    Zhang Z; Li T; Qu G; Pang Y; Zhao Y
    Int J Antimicrob Agents; 2015 Jan; 45(1):71-5. PubMed ID: 25459737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery and identification of serum potential biomarkers for pulmonary tuberculosis using iTRAQ-coupled two-dimensional LC-MS/MS.
    Xu DD; Deng DF; Li X; Wei LL; Li YY; Yang XY; Yu W; Wang C; Jiang TT; Li ZJ; Chen ZL; Zhang X; Liu JY; Ping ZP; Qiu YQ; Li JC
    Proteomics; 2014 Feb; 14(2-3):322-31. PubMed ID: 24339194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
    Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell cytokine responses in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis following stimulation with proteins purified from Mycobacterium tuberculosis MDR clinical isolates.
    Hadizadeh Tasbiti A; Yari S; Ghanei M; Siadat SD; Amanzadeh A; Tabarsi P; Saeedfar K; Bahrmand A
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S132-S133. PubMed ID: 28043507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
    Pang Y; Zhu D; Zheng H; Shen J; Hu Y; Liu J; Zhao Y
    BMC Infect Dis; 2017 Nov; 17(1):711. PubMed ID: 29110640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of moxifloxacin & econazole against multidrug resistant (MDR) Mycobacterium tuberculosis in murine model.
    Gupta UD; Vemuri N; Gupta P; Kumar V; Tanushree P; Khuller GK
    Indian J Med Res; 2015 Sep; 142(3):323-9. PubMed ID: 26458349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of multi-drug resistance & characterization of mutations in Mycobacterium tuberculosis isolates from North- Eastern States of India using GenoType MTBDRplus assay.
    Singhal R; Myneedu VP; Arora J; Singh N; Sah GC; Sarin R
    Indian J Med Res; 2014 Oct; 140(4):501-6. PubMed ID: 25488443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.